These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


390 related items for PubMed ID: 12771851

  • 1. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A, Limmert T, Hoffmann U.
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [Abstract] [Full Text] [Related]

  • 2. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
    Wilson AM, Ryan MC, Boyle AJ.
    Int J Cardiol; 2006 Jan 26; 106(3):291-7. PubMed ID: 16337036
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W, Piechota W.
    Pol Merkur Lekarski; 2005 May 26; 18(107):511-5. PubMed ID: 16161944
    [Abstract] [Full Text] [Related]

  • 4. C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
    Koenig W.
    Ital Heart J; 2001 Mar 26; 2(3):157-63. PubMed ID: 11305526
    [Abstract] [Full Text] [Related]

  • 5. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH, Newby LK.
    Cardiol Rev; 2003 Mar 26; 11(4):169-79. PubMed ID: 12852794
    [Abstract] [Full Text] [Related]

  • 6. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM.
    J Am Coll Cardiol; 2007 May 29; 49(21):2129-38. PubMed ID: 17531663
    [Abstract] [Full Text] [Related]

  • 7. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD, Rifai N.
    Cardiovasc Pathol; 2007 May 29; 16(1):14-21. PubMed ID: 17218210
    [Abstract] [Full Text] [Related]

  • 8. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W.
    Int J Cardiol; 2005 Feb 15; 98(2):199-206. PubMed ID: 15686768
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 10. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J, PROSPER Study Group.
    Circulation; 2007 Feb 27; 115(8):981-9. PubMed ID: 17283264
    [Abstract] [Full Text] [Related]

  • 11. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest J.
    Can J Cardiol; 2004 Aug 27; 20 Suppl B():89B-92B. PubMed ID: 15309211
    [Abstract] [Full Text] [Related]

  • 12. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS, Rifai N, Ridker PM.
    Curr Probl Cardiol; 2004 Aug 27; 29(8):439-93. PubMed ID: 15258556
    [Abstract] [Full Text] [Related]

  • 13. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.
    Ridker PM, Cook N.
    Circulation; 2004 Apr 27; 109(16):1955-9. PubMed ID: 15051634
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP.
    Circulation; 2005 Jul 05; 112(1):25-31. PubMed ID: 15983251
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 05; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 16. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S, Ridker PM.
    Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935
    [Abstract] [Full Text] [Related]

  • 17. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ.
    J Am Coll Cardiol; 2013 Jul 30; 62(5):397-408. PubMed ID: 23727085
    [Abstract] [Full Text] [Related]

  • 18. Baseline distribution and correlation analysis of hsCRP in an insurance applicant population.
    Krause KJ, Williams DS, White N.
    J Insur Med; 2008 Jul 30; 40(2):124-9. PubMed ID: 19119592
    [Abstract] [Full Text] [Related]

  • 19. [High-sensitivity C-reactive protein (CRP) assay--a novel method for assessment of risk ratios for atherosclerotic vascular diseases].
    Takahashi H.
    Rinsho Byori; 2002 Jan 30; 50(1):30-9. PubMed ID: 11871134
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L, Uzick M.
    Altern Med Rev; 2001 Jun 30; 6(3):248-71. PubMed ID: 11410071
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.